Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Dec 2010

Choi Yoon Hee, Lee Jin Kyung, Kang Hye Jin, Lee Tae Sup, Kim Hye-Ryoun, Kim Cheol Hyeon, Koh Jae Soo, Baek Hee Jong, Lee Jae Cheol, Na Im Il

Abstract excerpt

BACKGROUND: Our previous report showed an association between age and outcome in gefitinib-treated female patients with non-small cell lung cancer (NSCLC). Only limited numbers of molecular studies have been performed with respect to the presence of epidermal growth factor receptor (EGFR) mutations according to age. This retrospective study was performed to evaluate a possible association between age at the time...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to EGFR gene

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 21155184
DOI: 10.1097/jto.0b013e3181f38816

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer.PMID 21155184Read ↗

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.Semantic proximity Read ↗

Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors.Semantic proximity Read ↗

Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.Semantic proximity Read ↗

Epidermal growth factor receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung.Semantic proximity Read ↗

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.Semantic proximity Read ↗

Molecular characteristics of lung adenocarcinoma with respect to patient age at diagnosis.Semantic proximity Read ↗

Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors.Semantic proximity Read ↗

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.Semantic proximity Read ↗

Clinical features and outcomes of first-line EGFR-TKI treatment in younger and older patients with EGFR-mutated NSCLC.Semantic proximity Read ↗

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].Semantic proximity Read ↗

Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer.Semantic proximity Read ↗

Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.